--- title: "monday.com's AI Pivot and Tron's Token Buildup Highlight Small-Cap Realignments" type: "News" locale: "en" url: "https://longbridge.com/en/news/293818531.md" description: "Technology and biotech firms are aggressively restructuring in 2026. monday.com is slashing 20% of its workforce for an AI pivot, while Tron has expanded its token treasury past 700 million. Meanwhile, struggling TNL Mediagene faces a Nasdaq delisting." datetime: "2026-07-25T09:14:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293818531.md) - [en](https://longbridge.com/en/news/293818531.md) - [zh-HK](https://longbridge.com/zh-HK/news/293818531.md) --- # monday.com's AI Pivot and Tron's Token Buildup Highlight Small-Cap Realignments Technology and biotechnology firms are aggressively restructuring operations and accumulating digital assets to navigate the second half of 2026. Enterprise software provider monday.com is slashing 20% of its workforce to fund an AI pivot, while blockchain entity Tron has expanded its token treasury to over 700 million, according to recent company filings and market data. ### MONDAY.COM LTD (MNDY.US) monday.com is eliminating approximately 20% of its global workforce, taking a restructuring charge of USD 45 million to USD 55 million to accelerate its AI Work Platform strategy. Despite the significant headcount reduction, the company reaffirmed its full-year 2026 revenue growth forecast of 19% to 20% and raised its operating margin outlook to 15%, signaling improved profitability. Management expects the move to shift the focus away from traditional seat-based software models toward automated agent capabilities. ### MICWARE CO LTD (MWC.US) The Japanese automotive software supplier, which reported FY2026 revenue exceeding USD 140 million, is actively expanding its technological footprint beyond vehicle systems. Following the closure of its U.S. IPO in May, Micware announced the formation of Micware Spacia in July 2026 to target spatial intelligence and Web4 applications, cementing its position as a major Tier 1 software vendor in the Japanese ecosystem. ### SILICON LABORATORIES (SLAB.US) Silicon Labs reported Q1 2026 revenue of USD 214 million and non-GAAP EPS of USD 0.53, maintaining its grip on the IoT infrastructure market. The company recently advanced large-scale Matter deployments through a 200-node validation network and expanded its partnership with Signify for Philips Hue smart bulbs, shipping over 500,000 Wi-SUN modules through partners like Comminent. ### GD CULTURE GROUP LTD (GDC.US) The AI digital human creator announced a 1-for-250 reverse stock split in late June 2026 in an effort to regain Nasdaq listing compliance. The company also formed a special committee to evaluate a preliminary non-binding go-private proposal, shortly after executing a USD 5.45 million registered direct offering and acquiring Pallas Capital along with its Bitcoin assets. ### TNL MEDIAGENE (TNMG.US) The Tokyo-based digital media group, which generated USD 45 million in FY2025 revenue, is fighting to maintain its listing status. The company received a Nasdaq delisting notice in June 2026 for failing to meet the USD 1.00 minimum bid price and USD 2.5 million minimum stockholders' equity requirements, prompting management to request an official hearing. ### IMMUNITYBIO INC (IBRX.US) ImmunityBio posted Q1 2026 net product revenue of USD 44 million, representing a nearly 2.7 times year-over-year increase. The FDA has officially accepted its supplemental Biologics License Application for ANKTIVA in combination with BCG for non-muscle invasive bladder cancer, setting a PDUFA target date of January 6, 2027, following new clinical data presentations at the ASCO 2026 annual meeting. ### TRON INC (TRON.US) Tron reported Q1 2026 net income of USD 21.6 million on total assets of USD 252.7 million. In July 2026, the company purchased over 150,000 TRX tokens, pushing its on-chain inventory past 706 million tokens. The accumulation coincided with TRON's inclusion in the newly launched S&P Pantera Digital Asset Index. ### BIODEXA PHARMACEUTICALS (BDRX.US) The clinical-stage biopharmaceutical developer is advancing its pipeline of targeted therapeutics for unmet medical needs. Biodexa Pharmaceuticals continues its research operations through the first half of 2026, navigating a tight funding environment for early-stage biosciences and focusing on its core clinical trials without disclosing new major regulatory catalysts. ### NEXTCURE INC (NXTC.US) NextCure continues to evaluate its novel, first-in-class immunomedicines aimed at treating cancer and immune-related diseases. The company is advancing its core oncology pipeline into 2026, maintaining its clinical framework in a highly competitive immunotherapy landscape. ### AXTC (AXTC.US) AXTC remains an unclassified niche entity operating within the broader U.S. equities market. The company has maintained its baseline corporate structure through 2026, without disclosing new capital raises or strategic pivots to the public market. The diverging paths of these small-cap and mid-cap entities underscore a broader trend: firms are either leaning heavily into AI and digital asset realignments to secure funding, or facing severe listing and capitalization headwinds in an increasingly selective market environment. _This article does not constitute investment advice._ ### Related Stocks - [MNDY.US](https://longbridge.com/en/quote/MNDY.US.md) - [MWC.US](https://longbridge.com/en/quote/MWC.US.md) - [SLAB.US](https://longbridge.com/en/quote/SLAB.US.md) - [GDC.US](https://longbridge.com/en/quote/GDC.US.md) - [TNMG.US](https://longbridge.com/en/quote/TNMG.US.md) - [IBRX.US](https://longbridge.com/en/quote/IBRX.US.md) - [TRON.US](https://longbridge.com/en/quote/TRON.US.md) - [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md) - [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md) ## Related News & Research - [Tron to Pursue TRON Super Representative Role, Holds 709M TRX and $15.8M Cumulative Gain](https://longbridge.com/en/news/295799670.md) - [Silicon Labs (SLAB) Stock Looks Above Fair Value After A 67% Run](https://longbridge.com/en/news/295701631.md) - [Silicon Labs Sr VP, General Manager Robert J. Conrad sells 6,581 shares for $1.44 million](https://longbridge.com/en/news/296137602.md) - [Silicon Labs Q2 revenue rises on segment growth; co suspends guidance on pending acquisition](https://longbridge.com/en/news/295574062.md) - [MNDY: Q2 revenue up 22% YoY, AI ARR doubled, and large customer growth accelerated](https://longbridge.com/en/news/295405384.md)